Makki Nader, Dollery Jenn, Jones Danielle, Crestanello Juan, Lilly Scott
Department of Cardiology, Ohio State University Wexner Medical Center, Columbus, OH, 43210.
Department of Cardiothoracic Surgery, Ohio State University Wexner Medical Center, Columbus, OH, 43210.
Cardiovasc Revasc Med. 2017 Jul-Aug;18(5S1):S10-S13. doi: 10.1016/j.carrev.2017.03.009. Epub 2017 Mar 15.
Permanent pacemaker (PPM) placement occurs in 5-20% of patients after transcatheter aortic valve replacement (TAVR). Although predictors of pacemaker implantation have been established, features that predispose patients to pacemaker utilization on follow up have not been widely reported.
We performed a retrospective review of patients undergoing commercial TAVR between 2011 and 2016. We collated patients that underwent in-hospital PPM implantation and had a follow up of at least 3months. Data abstraction was performed for electrophysiological studies (EPS), pacemaker indication, timing, and device interrogation for pacemaker dependency on follow up.
A total of 24 patients received in-hospital PPM post-TAVR (14% of total cohort), and mean follow up was 22months. Indications for PPM included resting complete heart block (CHB; 15/24, 63%), left bundle branch block and abnormal electrophysiological study (EPS; 7/24, 29%), alternating bundle branch block (1/24, 4%) and tachy-brady syndrome (1/24, 4%). Pacemaker dependency (underlying ventricular asystole, complete heart block, or >50% pacing) occurred in 8/24 patients (33%) during follow-up, 7 of whom had resting CHB, and one with CHB invoked during EPS.
Pacemaker dependency after TAVR is common among those that exhibited CHB, but not among those with a prolonged HV delay during EPS. Although preliminary, these observations are relevant to management of rhythm disturbances after TAVR, and may inform the practice of EPS-based PPM implantation.
经导管主动脉瓣置换术(TAVR)后,5%-20%的患者需要植入永久性起搏器(PPM)。虽然已经确定了起搏器植入的预测因素,但关于哪些特征会使患者在随访中倾向于使用起搏器的情况尚未有广泛报道。
我们对2011年至2016年间接受商业TAVR的患者进行了回顾性研究。我们整理了住院期间植入PPM且随访至少3个月的患者。对电生理研究(EPS)、起搏器指征、时间以及随访期间起搏器依赖情况的设备询问进行了数据提取。
共有24例患者在TAVR后住院期间接受了PPM植入(占总队列的14%),平均随访时间为22个月。PPM的指征包括静息性完全性心脏传导阻滞(CHB;15/24,63%)、左束支传导阻滞和异常电生理研究(EPS;7/24,29%)、交替性束支传导阻滞(1/24,4%)和心动过缓-心动过速综合征(1/24,4%)。随访期间,8/24例患者(33%)出现起搏器依赖(基础心室停搏、完全性心脏传导阻滞或起搏比例>50%),其中7例有静息性CHB,1例在EPS期间出现CHB。
TAVR后起搏器依赖在表现为CHB的患者中很常见,但在EPS期间HV间期延长的患者中并不常见。虽然这些观察结果是初步的,但与TAVR后心律失常的管理相关,可能为基于EPS的PPM植入实践提供参考。